Explore

Trendline Trendline
MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
Trendline Trendline
Potential FDA Leadership Change Could Impact Biopharma Industry

Potential FDA Leadership Change Could Impact Biopharma Industry

Potential FDA Leadership Change Could Impact Biopharma Industry
Trendline Trendline
MacroGenics Sells Maryland Drug Plant to Bora for $122.5 Million, Impacting 140 Workers

MacroGenics Sells Maryland Drug Plant to Bora for $122.5 Million, Impacting 140 Workers

MacroGenics Sells Maryland Drug Plant to Bora for $122.5 Million, Impacting 140 Workers
Trendline Trendline
Avid Bioservices Names Kerri McCullough Wood as Chief Commercial Officer to Drive Growth

Avid Bioservices Names Kerri McCullough Wood as Chief Commercial Officer to Drive Growth

Avid Bioservices Names Kerri McCullough Wood as Chief Commercial Officer to Drive Growth
Trendline Trendline
Forge Biologics to Present Gene Therapy Advancements at ASGCT Annual Meeting

Forge Biologics to Present Gene Therapy Advancements at ASGCT Annual Meeting

Forge Biologics to Present Gene Therapy Advancements at ASGCT Annual Meeting
Trendline Trendline
Healthtech Companies Face Implementation Challenges Amid Digital Transformation

Healthtech Companies Face Implementation Challenges Amid Digital Transformation

Healthtech Companies Face Implementation Challenges Amid Digital Transformation
Trendline Trendline
MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million

MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million

MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million
Trendline Trendline
Potential Removal of FDA Commissioner Makary Could Benefit Biopharma Industry

Potential Removal of FDA Commissioner Makary Could Benefit Biopharma Industry

Potential Removal of FDA Commissioner Makary Could Benefit Biopharma Industry
Trendline Trendline
MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals

MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals
Trendline Trendline
OpenAI CEO Sam Altman Highlights Gen Z's Use of ChatGPT as a Life Advisor

OpenAI CEO Sam Altman Highlights Gen Z's Use of ChatGPT as a Life Advisor

OpenAI CEO Sam Altman Highlights Gen Z's Use of ChatGPT as a Life Advisor
Trendline Trendline
Tech Mahindra and UKG Collaborate to Enhance AI-Driven Workforce Solutions

Tech Mahindra and UKG Collaborate to Enhance AI-Driven Workforce Solutions

Tech Mahindra and UKG Collaborate to Enhance AI-Driven Workforce Solutions
Trendline Trendline
Atossa Therapeutics Reports Q1 2026 Financial Results and Strategic Developments

Atossa Therapeutics Reports Q1 2026 Financial Results and Strategic Developments

Atossa Therapeutics Reports Q1 2026 Financial Results and Strategic Developments